QC
BPMC

Quadrature Capital’s Blueprint Medicines BPMC Stock Holding History

Quadrature Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-382,677
Closed -$49.1M – 1075
2025
Q2 		$49.1M Buy
+382,677
New +$39.7M 0.85% 24

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quadrature Capital's BPMC Position: Q3 2025 in Review

Quadrature Capital sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 382,677 shares — an estimated $49.1M sold.

Quadrature Capital first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $49.1M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Quadrature Capital reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Quadrature Capital sold 382,677 Blueprint Medicines shares in Q3 2025, an estimated $49.1M.
  • Quadrature Capital first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Quadrature Capital's Blueprint Medicines position peaked at $49.1M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.